Syndax Pharmaceuticals, Inc. (SNDX)

NASDAQ: SNDX · IEX Real-Time Price · USD

23.08

-0.14 (-0.60%)

At close: Jul 19, 2024, 4:00 PM

23.10

+0.02 (0.09%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Syndax Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Revenue	0	0	0	139.71	1.52	1.52	Upgrade
Revenue Growth (YoY)	-	-	-	9109.56%	0%	0%	Upgrade
Gross Profit	0	0	0	139.71	1.52	1.52	Upgrade
Selling, General & Admin	77.98	66.92	33.26	25.24	22.51	16.06	Upgrade
Research & Development	185.47	163.03	118.5	88.25	50.44	42.99	Upgrade
Operating Expenses	263.45	229.95	151.76	113.49	72.94	59.06	Upgrade
Operating Income	-263.45	-229.95	-151.76	26.22	-71.42	-57.54	Upgrade
Interest Expense / Income	0.22	0.21	3.14	1.9	2.36	0	Upgrade
Other Expense / Income	-23.04	-20.8	-5.56	-0.61	3.28	-1.49	Upgrade
Pretax Income	-240.63	-209.36	-149.34	24.93	-77.06	-56.05	Upgrade
Net Income	-240.63	-209.36	-149.34	24.93	-77.06	-56.05	Upgrade
Shares Outstanding (Basic)	85	70	61	52	41	30	Upgrade
Shares Outstanding (Diluted)	85	70	61	54	41	30	Upgrade
Shares Change	22.72%	15.82%	13.31%	29.81%	35.48%	20.18%	Upgrade
EPS (Basic)	-3.23	-2.98	-2.46	0.48	-1.87	-1.84	Upgrade
EPS (Diluted)	-3.23	-2.98	-2.46	0.46	-1.87	-1.84	Upgrade
Free Cash Flow	-204.92	-160.6	-133.45	29	-71.26	-50.61	Upgrade
Free Cash Flow Per Share	-2.40	-2.28	-2.20	0.56	-1.73	-1.66	Upgrade
Gross Margin	-	-	-	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	18.77%	-4708.17%	-3792.95%	Upgrade
Profit Margin	-	-	-	17.84%	-5080.03%	-3694.59%	Upgrade
Free Cash Flow Margin	-	-	-	20.76%	-4697.43%	-3336.32%	Upgrade
EBITDA	-239.53	-208.4	-145.75	27.28	-74.19	-55.6	Upgrade
EBITDA Margin	-	-	-	19.53%	-4890.71%	-3664.86%	Upgrade
Depreciation & Amortization	0.89	0.75	0.45	0.46	0.52	0.45	Upgrade
EBIT	-240.41	-209.15	-146.2	26.83	-74.71	-56.05	Upgrade
EBIT Margin	-	-	-	19.20%	-4924.65%	-3694.59%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).